Cargando…
Primary CNS lymphoproliferative disease, mycophenolate and calcineurin inhibitor usage
Immunosuppression for solid organ transplantation increases lymphoproliferative disease risk. While central nervous system (CNS) involvement is more rare, we noticed an increase in primary CNS (PCNS) disease. To investigate a potential association with the immunosuppressive regimen we identified all...
Autores principales: | Crane, Genevieve M., Powell, Helen, Kostadinov, Rumen, Rocafort, Patrick Tim, Rifkin, Dena E., Burger, Peter C., Ambinder, Richard F., Swinnen, Lode J., Borowitz, Michael J., Duffield, Amy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741807/ https://www.ncbi.nlm.nih.gov/pubmed/26460822 |
Ejemplares similares
-
Eosinophilic granulomatosis with polyangiitis (EGPA) on remission with a new neuropathy: a rare case of mycophenolate induced primary CNS lymphoproliferative disease
por: Shrestha, Pragya, et al.
Publicado: (2020) -
Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLE
por: van Gelder, Teun, et al.
Publicado: (2021) -
A Rare Presentation of Isolated CNS Posttransplantation Lymphoproliferative Disorder
por: Morris, Jaime, et al.
Publicado: (2017) -
Mycophenolate mofetil alters the antioxidant status in duodenum of rats: Implication for silymarin usage in mycophenolate mofetil-induced gastrointestinal disorders
por: Sheikhzadeh, Sanaz, et al.
Publicado: (2013) -
Molecular profiling identifies at least 3 distinct types of posttransplant lymphoproliferative disorder involving the CNS
por: Guney, Ekin, et al.
Publicado: (2023)